Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825252 | SCV000966537 | likely benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Ser121Ser in Exon 05 of TRIOBP: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.2% (7/3518) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS). |
Labcorp Genetics |
RCV000906640 | SCV001051291 | benign | not provided | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000906640 | SCV001803063 | likely benign | not provided | 2021-03-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000906640 | SCV005206417 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003965607 | SCV004779935 | likely benign | TRIOBP-related disorder | 2020-03-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |